These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence and outcomes of heparin-induced thrombocytopenia in hospitalized patients with venous thromboembolic disease: Insight from national inpatient sample. Shah NB; Sharedalal P; Shafi I; Tang A; Zhao H; Lakhter V; Kolluri R; Rao AK; Bashir R J Vasc Surg Venous Lymphat Disord; 2023 Jul; 11(4):723-730. PubMed ID: 36893884 [TBL] [Abstract][Full Text] [Related]
6. The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis. Dasenbrock HH; Yan SC; Gross BA; Guttieres D; Gormley WB; Frerichs KU; Ali Aziz-Sultan M; Du R J Neurosurg; 2017 Feb; 126(2):537-547. PubMed ID: 27058205 [TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France. Elalamy I; Le Gal G; Nachit-Ouinekh F; Lafuma A; Emery C; Le-Fur C; Chapuis F Clin Appl Thromb Hemost; 2009; 15(4):428-34. PubMed ID: 18544593 [TBL] [Abstract][Full Text] [Related]
8. Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control study. Gettings EM; Brush KA; Van Cott EM; Hurford WE Crit Care; 2006; 10(6):R161. PubMed ID: 17109753 [TBL] [Abstract][Full Text] [Related]
9. Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). Lopes RD; Ohman EM; Granger CB; Honeycutt EF; Anstrom KJ; Berger PB; Crespo EM; Oliveira GB; Moll S; Moliterno DJ; Abrams CS; Becker RC Am J Cardiol; 2009 Nov; 104(9):1285-91. PubMed ID: 19840578 [TBL] [Abstract][Full Text] [Related]
10. Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries. Happe LE; Farrelly EM; Stanford RH; Sarnes MW J Thromb Thrombolysis; 2008 Oct; 26(2):125-31. PubMed ID: 18034323 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HIT. Carlson DS; Bartholomew JR; Gomes MP; McCrae KR; Chaturvedi S Thromb Haemost; 2020 Feb; 120(2):300-305. PubMed ID: 31887779 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ; JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228 [TBL] [Abstract][Full Text] [Related]
13. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft. Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457 [TBL] [Abstract][Full Text] [Related]
14. Incidence, Outcomes and Risk Factors of Heparin-Induced Thrombocytopenia After Total Joint Arthroplasty: A National Inpatient Sample Database Study. Chen Y; Wang J; Shi ZJ; Zhang Y; Yang Q; Xu Y Clin Appl Thromb Hemost; 2021; 27():10760296211042938. PubMed ID: 34558329 [No Abstract] [Full Text] [Related]
15. Medical and Economic Burden of Heparin-Induced Thrombocytopenia: A Retrospective Nationwide Inpatient Sample (NIS) Study. Pathak R; Bhatt VR; Karmacharya P; Aryal MR; Donato AA J Hosp Med; 2017 Feb; 12(2):94-97. PubMed ID: 28182804 [TBL] [Abstract][Full Text] [Related]
16. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Smythe MA; Koerber JM; Mattson JC Chest; 2007 Jun; 131(6):1644-9. PubMed ID: 17400685 [TBL] [Abstract][Full Text] [Related]
17. Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study. Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Akinyemiju T; Onwuemene OA J Clin Apher; 2021 Jun; 36(3):398-407. PubMed ID: 33453132 [TBL] [Abstract][Full Text] [Related]
18. The financial impact of heparin-induced thrombocytopenia. Smythe MA; Koerber JM; Fitzgerald M; Mattson JC Chest; 2008 Sep; 134(3):568-573. PubMed ID: 18490399 [TBL] [Abstract][Full Text] [Related]
19. Adaptation of the Risk Analysis Index for Frailty Assessment Using Diagnostic Codes. Dicpinigaitis AJ; Khamzina Y; Hall DE; Nassereldine H; Kennedy J; Seymour CW; Schmidt M; Reitz KM; Bowers CA JAMA Netw Open; 2024 May; 7(5):e2413166. PubMed ID: 38787554 [TBL] [Abstract][Full Text] [Related]
20. Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: an analysis of the nationwide inpatient sample. Seigerman M; Cavallaro P; Itagaki S; Chung I; Chikwe J J Cardiothorac Vasc Anesth; 2014 Feb; 28(1):98-102. PubMed ID: 24295719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]